Get access

Genomics and Cardiovascular Disease

Authors

  • Lorraine Frazier,

    1. Lorraine Frazier, RN, DSN, NP, Zeta Pi, Associate Professor, The University of Texas Health Science Center at Houston School of Nursing, Houston, TX; Rolanda L. Johnson, RN, MSN, PhD, Iota, Assistant Professor of Nursing, Vanderbilt University School of Nursing, Nashville, TN; Elizabeth Sparks, RN, MS, CS, APNG, Clinical Assistant Professor of Medicine, The Ohio State University, Dept. of Internal Medicine, Cardiology Division, The Heart Center at Columbus Children's Hospital, Columbus, OH. This work was supported in part by Grant K23 NR08427-02 from the National Institute for Nursing Research, National Institutes of Health. Correspondence to Dr. Frazier, 6901 Bertner, Suite 578, Houston, TX 77030. E-mail: Lorraine.Frazier@uth.tmc.edu
    Search for more papers by this author
  • Rolanda L. Johnson,

    1. Lorraine Frazier, RN, DSN, NP, Zeta Pi, Associate Professor, The University of Texas Health Science Center at Houston School of Nursing, Houston, TX; Rolanda L. Johnson, RN, MSN, PhD, Iota, Assistant Professor of Nursing, Vanderbilt University School of Nursing, Nashville, TN; Elizabeth Sparks, RN, MS, CS, APNG, Clinical Assistant Professor of Medicine, The Ohio State University, Dept. of Internal Medicine, Cardiology Division, The Heart Center at Columbus Children's Hospital, Columbus, OH. This work was supported in part by Grant K23 NR08427-02 from the National Institute for Nursing Research, National Institutes of Health. Correspondence to Dr. Frazier, 6901 Bertner, Suite 578, Houston, TX 77030. E-mail: Lorraine.Frazier@uth.tmc.edu
    Search for more papers by this author
  • Elizabeth Sparks

    1. Lorraine Frazier, RN, DSN, NP, Zeta Pi, Associate Professor, The University of Texas Health Science Center at Houston School of Nursing, Houston, TX; Rolanda L. Johnson, RN, MSN, PhD, Iota, Assistant Professor of Nursing, Vanderbilt University School of Nursing, Nashville, TN; Elizabeth Sparks, RN, MS, CS, APNG, Clinical Assistant Professor of Medicine, The Ohio State University, Dept. of Internal Medicine, Cardiology Division, The Heart Center at Columbus Children's Hospital, Columbus, OH. This work was supported in part by Grant K23 NR08427-02 from the National Institute for Nursing Research, National Institutes of Health. Correspondence to Dr. Frazier, 6901 Bertner, Suite 578, Houston, TX 77030. E-mail: Lorraine.Frazier@uth.tmc.edu
    Search for more papers by this author

Abstract

Purpose: To describe genetic knowledge and discovery in the area of cardiovascular disease (CVD) and to discuss how these new advances will influence the clinical care of affected people.

Organizing Framework: A selective review of the literature is presented on the disease mechanism of both the Mendelian and multifactorial genetic cardiovascular conditions. A case study approach is used to illustrate how the genetic paradigm affects the healthcare experience of a family affected with familial hypertrophic cardiomyopathy.

Findings: The current state of CVD treatment remains complex. An understanding of genomic concepts and a genome-based approach is necessary to determine: (a) the risk of CVD susceptibility beyond traditional risk factors; (b) early detection of illness; (c) response to treatment; and (d) molecular taxonomy of the disease.

Conclusions: The results of genetic research, education, and teaching will lead to a new understanding of genes and pathways, resulting in powerful new therapeutic approaches to CVD. The challenge is to translate genetic discoveries into clinical practice that ultimately leads to preventing CVD and reducing mortality.

Ancillary